Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.

MLA

Chang, Lee-Hsin, et al. “Thrombus-Specific Theranostic Nanocomposite for Codelivery of Thrombolytic Drug, Algae-Derived Anticoagulant and NIR Fluorescent Contrast Agent.” Acta Biomaterialia, vol. 134, Oct. 2021, pp. 686–701. EBSCOhost, https://doi.org/10.1016/j.actbio.2021.07.072.

APA

Chang, L.-H., Chuang, E.-Y., Cheng, T.-M., Lin, C., Shih, C.-M., Wu, A. T., Jheng, P.-R., Lu, H.-Y., Shih, C.-C., & Mi, F.-L. (2021). Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent. Acta Biomaterialia, 134, 686–701. https://doi.org/10.1016/j.actbio.2021.07.072

Chicago

Chang, Lee-Hsin, Er-Yuan Chuang, Tsai-Mu Cheng, Chi Lin, Chun-Ming Shih, Alexander Th Wu, Pei-Ru Jheng, Hsin-Ying Lu, Chun-Che Shih, and Fwu-Long Mi. 2021. “Thrombus-Specific Theranostic Nanocomposite for Codelivery of Thrombolytic Drug, Algae-Derived Anticoagulant and NIR Fluorescent Contrast Agent.” Acta Biomaterialia 134 (October): 686–701. doi:10.1016/j.actbio.2021.07.072.